+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pharmacokinetic study of ATRA and the intermittent and cyclic regimen with ATRA and chemotherapy in pediatric acute promyelocytic leukemia



Pharmacokinetic study of ATRA and the intermittent and cyclic regimen with ATRA and chemotherapy in pediatric acute promyelocytic leukemia



Blood 90(10 Suppl. 1 Part 2): 245B




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 032777358

Download citation: RISBibTeXText


Related references

Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group. Japanese Journal of Clinical Hematology 38(11): 1170-1176, 1997

Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group. Japanese Journal of Clinical Hematology 38(11): 1177-1182, 1997

Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone. American Journal of Hematology 60(2): 87-93, 1999

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94(4): 1192-1200, 1999

Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines. European Journal of Haematology 100(2): 154-162, 2018

ATRA followed by chemotherapy vs ATRA plus CT, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia Results of APL 93 trial. Annals of Hematology 78(Suppl. 2): S14, 1999

ATRA followed by chemotherapy vs ATRA plus CT and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia First interim results of APL 93 trial. Blood 90(10 Suppl. 1 Part 1): 122A, 1997

ATRA followed by chemotherapy vs ATRA plus CT, and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia Long term follow up of APL 93 trial. Blood 98(11 Part 1): 766a, 2001

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy. Annals of Hematology 97(10): 1797-1802, 2018

Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose ara-C and maintenance with intermittent all-trans retinoic acid (ATRA). Leukemia and Lymphoma 36(5-6): 625-629, 2000

All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1 -mutated AML unfit for intensive chemotherapy and review of the literature. Clinical Case Reports 4(12): 1138-1146, 2016

CNS relapse in a low risk acute promyelocytic leukemia patient treated with ATRA-based regimen: is there a role for prophylactic CNS therapy in acute promyelocytic leukemia?. Indian Journal of Hematology and Blood Transfusion 25(3): 118-119, 2009

Effect of curcumin combined with ATRA on differentiation of ATRA-resistant acute promyelocytic leukemia cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi 21(4): 895-898, 2013

The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK. Food and Chemical Toxicology 126: 303-312, 2019

Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy. Leukemia and Lymphoma 60(5): 1146-1155, 2019